Madrigal Pharmaceuticals IncNASDAQ:MDGL
- LAST PRICE335.1599
- TODAY'S CHANGE (%)-4.5001 (-1.3249%)
- Bid / Lots334.5900/ 8
- Ask / Lots335.1600/ 8
- Open / Previous Close335.5700 / 339.6600
- Day Range
- 52 Week Range
- Volume160,656
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MDGL |
|---|---|---|
| 09:32 ET | 3294 | 335.13 |
| 09:33 ET | 647 | 334 |
| 09:35 ET | 1635 | 336.6 |
| 09:39 ET | 100 | 340.19 |
| 09:42 ET | 200 | 338.985 |
| 09:44 ET | 299 | 337.21 |
| 09:46 ET | 100 | 339.44 |
| 09:48 ET | 100 | 338.94 |
| 09:50 ET | 958 | 340.205 |
| 09:51 ET | 100 | 340.205 |
| 09:53 ET | 500 | 339.14 |
| 09:55 ET | 300 | 336.755 |
| 09:57 ET | 300 | 337.27 |
| 10:00 ET | 350 | 337.6642 |
| 10:02 ET | 100 | 337.17 |
| 10:04 ET | 745 | 336.35 |
| 10:06 ET | 100 | 336.81 |
| 10:09 ET | 1700 | 337.325 |
| 10:11 ET | 750 | 337.66 |
| 10:13 ET | 601 | 337.855 |
| 10:18 ET | 200 | 336.72 |
| 10:20 ET | 100 | 336.265 |
| 10:22 ET | 200 | 335.79 |
| 10:24 ET | 100 | 335.71 |
| 10:26 ET | 1000 | 334.03 |
| 10:27 ET | 3691 | 335.015 |
| 10:31 ET | 500 | 334.02 |
| 10:36 ET | 100 | 335.075 |
| 10:38 ET | 200 | 334.3001 |
| 10:40 ET | 5394 | 332.5 |
| 10:42 ET | 2045 | 333.21 |
| 10:44 ET | 300 | 332.58 |
| 10:47 ET | 296 | 333.555 |
| 10:49 ET | 806 | 333.48 |
| 10:51 ET | 100 | 333.89 |
| 10:54 ET | 500 | 334.07 |
| 10:56 ET | 200 | 333.39 |
| 10:58 ET | 100 | 332.975 |
| 11:00 ET | 1790 | 333 |
| 11:03 ET | 774 | 332.84 |
| 11:05 ET | 200 | 333.04 |
| 11:07 ET | 100 | 333.31 |
| 11:09 ET | 480 | 332.65 |
| 11:14 ET | 500 | 332.78 |
| 11:16 ET | 1476 | 330.4 |
| 11:18 ET | 3747 | 329.18 |
| 11:20 ET | 1860 | 328.52 |
| 11:21 ET | 200 | 328.63 |
| 11:25 ET | 1800 | 329.105 |
| 11:27 ET | 1031 | 329.545 |
| 11:30 ET | 100 | 329.12 |
| 11:32 ET | 560 | 329.12 |
| 11:34 ET | 100 | 329.8 |
| 11:36 ET | 300 | 329.8 |
| 11:39 ET | 333 | 329.82 |
| 11:41 ET | 300 | 329.99 |
| 11:43 ET | 865 | 330.3 |
| 11:48 ET | 4996 | 328.185 |
| 11:50 ET | 200 | 328.4 |
| 11:52 ET | 222 | 327.45 |
| 11:54 ET | 200 | 328.6302 |
| 11:56 ET | 3147 | 329.275 |
| 11:59 ET | 100 | 328.98 |
| 12:01 ET | 200 | 328.74 |
| 12:03 ET | 600 | 328.47 |
| 12:06 ET | 1659 | 329.45 |
| 12:12 ET | 200 | 330.1711 |
| 12:14 ET | 100 | 329.61 |
| 12:19 ET | 1700 | 329.96 |
| 12:26 ET | 100 | 329.33 |
| 12:28 ET | 1510 | 330.18 |
| 12:30 ET | 1295 | 331.1585 |
| 12:32 ET | 472 | 331.055 |
| 12:33 ET | 300 | 331.28 |
| 12:35 ET | 300 | 331.23 |
| 12:39 ET | 503 | 331.22 |
| 12:42 ET | 526 | 330.56 |
| 12:44 ET | 500 | 330.3 |
| 12:46 ET | 1400 | 331.045 |
| 12:48 ET | 940 | 331.17 |
| 12:50 ET | 854 | 331.5 |
| 12:51 ET | 500 | 332 |
| 12:55 ET | 100 | 332.065 |
| 01:00 ET | 503 | 331.7 |
| 01:02 ET | 100 | 331.765 |
| 01:04 ET | 636 | 332.38 |
| 01:06 ET | 200 | 332.605 |
| 01:09 ET | 100 | 332.77 |
| 01:11 ET | 1900 | 331.96 |
| 01:13 ET | 200 | 332.04 |
| 01:15 ET | 402 | 331.69 |
| 01:20 ET | 100 | 331.54 |
| 01:24 ET | 200 | 331.38 |
| 01:27 ET | 900 | 332.59 |
| 01:29 ET | 600 | 333.6 |
| 01:31 ET | 1852 | 334.01 |
| 01:33 ET | 1186 | 335 |
| 01:36 ET | 1813 | 335.1 |
| 01:38 ET | 732 | 335.04 |
| 01:40 ET | 1100 | 334.75 |
| 01:44 ET | 200 | 334.23 |
| 01:47 ET | 255 | 335.1599 |
Nov 6, 2024
Madrigal Pharmaceuticals, Inc. Announces Participation at Three Upcoming Investor Conferences, from 8:00AM ET on Wednesday Nov 06, 2024 by Dow Jones
8:00AM ET on Wednesday Nov 06, 2024 by Dow Jones
Nov 5, 2024
DJ Madrigal Pharmaceuticals Is Maintained at Neutral by B. Riley Securities, from 11:22AM ET on Tuesday Nov 05, 2024 by Dow Jones
11:22AM ET on Tuesday Nov 05, 2024 by Dow Jones
Nov 1, 2024
DJ Madrigal Pharmaceuticals Is Maintained at Buy by UBS, from 2:37PM ET on Friday Nov 01, 2024 by Dow Jones
2:37PM ET on Friday Nov 01, 2024 by Dow Jones
Oct 31, 2024
Madrigal Pharmaceuticals Reports Third-Quarter 2024 Financial Results and Provides Corporate Updates, from 7:01AM ET on Thursday Oct 31, 2024 by Dow Jones
7:01AM ET on Thursday Oct 31, 2024 by Dow Jones*DJ Madrigal Pharmaceuticals 3Q Loss/Shr $4.92 >MDGL, from 7:01AM ET on Thursday Oct 31, 2024 by Dow Jones
7:01AM ET on Thursday Oct 31, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Madrigal Pharmaceuticals Inc | 7.4B | -13.4x | --- |
Viking Therapeutics Inc | 7.0B | -62.1x | --- |
Cytokinetics Inc | 6.9B | -10.5x | --- |
Nuvalent Inc | 6.2B | -32.5x | --- |
Legend Biotech Corp | 7.4B | -25.5x | --- |
Avidity Biosciences Inc | 5.5B | -16.0x | --- |
Company Information
Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH). The Company's product candidate, resmetirom, is a once-daily, oral, liver-directed thyroid hormone receptor-β (THR-β) agonist designed to target key underlying causes of NASH. NASH is a more advanced form of non-alcoholic fatty liver disease (NAFLD). The Company’s clinical development program includes MAESTRO-NASH, MAESTRO-NAFLD-1, and MAESTRO-NASH OUTCOMES.
Contact Information
- Headquarters
- 200 Barr Harbor Dr Ste 400WEST CONSHOHOCKEN, PA, United States 19428-2978
- Phone
- 404-380-9263
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Julian Baker
- President, Chief Executive Officer, Director
- Bill Sibold
- Chief Financial Officer, Senior Vice President
- Mardi Dier
- President of Research and Development, Chief Medical Officer, Director
- Rebecca Taub
- Senior Vice President - Clinical Development
- Michael Charlton
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $7.4B |
|---|---|
Revenue (TTM) | $76.8M |
Shares Outstanding | 21.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.42 |
EPS | $-25.07 |
Book Value | $20.39 |
P/E Ratio | -13.4x |
Price/Sales (TTM) | 96.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -713.49% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
